Surgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue Sarcoma
Childhood Malignant Fibrous Histiocytoma of Bone, Sarcoma
About this trial
This is an interventional treatment trial for Childhood Malignant Fibrous Histiocytoma of Bone focused on measuring embryonal childhood rhabdomyosarcoma, alveolar childhood rhabdomyosarcoma, pleomorphic childhood rhabdomyosarcoma, mixed childhood rhabdomyosarcoma, embryonal-botryoid childhood rhabdomyosarcoma, nonmetastatic childhood soft tissue sarcoma, childhood fibrosarcoma, childhood synovial sarcoma, childhood malignant hemangiopericytoma, childhood liposarcoma, childhood alveolar soft-part sarcoma, childhood leiomyosarcoma, childhood neurofibrosarcoma, childhood angiosarcoma, childhood epithelioid sarcoma, childhood malignant fibrous histiocytoma of bone, childhood malignant mesenchymoma, previously untreated childhood rhabdomyosarcoma, childhood desmoplastic small round cell tumor, localized Ewing sarcoma/peripheral primitive neuroectodermal tumor
Eligibility Criteria
DISEASE CHARACTERISTICS: Histologically confirmed primary soft tissue sarcoma: Rhabdomyosarcoma Non-rhabdomyosarcoma Soft tissue primitive neuroectodermal tumor (PNET) Extraosseous Ewing's sarcoma PATIENT CHARACTERISTICS: Age: Under 18 Performance status: Not specified Life expectancy: Not specified Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified PRIOR CONCURRENT THERAPY: Biologic: Not specified Chemotherapy: Not specified Endocrine: Not specified Radiotherapy: Not specified Surgery: Prior primary surgery allowed Other: No other prior therapy
Sites / Locations
- Institute of Child Health